St. Louis-based Defender Pharmaceuticals, with $70M in funding, eyes approval for lead drug candidate

A Town & County-based life sciences firm that has raised $70 million from investors hopes to soon be able to commercialize a drug candidate it has developed to prevent vomiting and nausea from motion sickness.